rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

SBC Medical Group Holdings Incorporated

SBC · Nasdaq

Health CareProviders & FacilitiesIn trend

SBC stood above a rising 150-day average in 9 of the last 52 weekly readings, including each of the last 4 weeks. It is 38.5% above that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
In trend
Weeks in an uptrend
4 in a row
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$40.3M
Officials’ trades on record
0
Institutions holding
58 (+11)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$20.8M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months3
Buyers · sellers0 · 1
WhoDidSharesTraded
Yoshiyuki AikawaChairman and CEOsold465,000at $3.0228 Apr 2026filed 29 Apr 2026
Yoshiyuki AikawaChairman and CEOsold3,100,000at $3.0221 Apr 2026filed 23 Apr 2026
Yoshiyuki AikawaChairman and CEOsold4,422,900at $2.126 Mar 2026filed 10 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders58+11 on the quarter
New · exited16 · 6
Reported value$13.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Lumbard & Kellner, LLCadded · filed 6 Aug 20261,727,208$5.3M+1,709,935+9899.5%
BlackRock, Inc.added · filed 7 Aug 2026924,002$2.8M+504,362+120.2%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026427,864$1.3M+132,085+44.7%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026144,718$446K+144,718
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026135,783$418K-456−0.3%
NORTHERN TRUST CORPadded · filed 13 Aug 2026131,204$404K+40,065+44.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026128,295$395K+64,748+101.9%
Hillsdale Investment Management Inc.new · filed 12 Aug 2026124,800$384K+124,800
SEGALL BRYANT & HAMILL, LLCnew · filed 12 Aug 202681,307$250K+81,307
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202666,281$204K+3,808+6.1%
31 Mar 2023 – 30 Jun 2026
43056Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Yoshiyuki Aikawa Company insiderChairman and CEO · last 28 Apr 20260 · 3
Mike K. Sayama Company insiderDirector · last 30 Sep 20240 · 0
Zuu Funders Co. Ltd. Company insider10% owner · last 19 Sep 20246 · 1
Zuu Target Fund For Sbc Medical Group Hd Investment Partnership Company insider10% owner · last 22 Aug 202412 · 1
Kazumasa Tomita Company insider10% owner · last 20 Aug 202422 · 2
Zuu Co. Ltd. Company insider10% owner · last 19 Jul 202412 · 0
Dustin M. Shindo Company insiderDirector, 10% owner · last 9 Aug 20221 · 0
Mehana Capital Llc Company insider10% owner · last 9 Aug 20221 · 0

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202573.3%
Operating profit marginFY 2025 · to 31 Dec 202538.9%
Free cash flow marginFY 2025 · to 31 Dec 202513.4%
Return on capital employedFY 2025 · to 31 Dec 202521.1%
Cash conversionFY 2025 · to 31 Dec 202548.4%
Debt to equityFY 2025 · to 31 Dec 20250.17×
Interest coverFY 2025 · to 31 Dec 2025455.26×
Share count trendFY 2025 · to 28 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$163.8M
Free cash flowFY 2025 · to 31 Dec 2025$23.3M

Analyst forecasts

No analyst forecasts yet.